Two potential biomarkers identified in mesenchymal stem cells and leukocytes of patients with sporadic amyotrophic lateral sclerosis

Disease Markers

Volumn 32, Issue 4, 2012, Pages 211-220

  Nachmany, Henny ^a   Wald, Shane ^a   Abekasis, Michal ^a   Bulvik, Shlomo ^b   Weil, Miguel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b LANIADO HOSPITAL   (Israel)

Author keywords

ALS biomarkers; CyFIP2; human mesenchymal stem cells; leukocytes; RbBP9

Indexed keywords

BIOLOGICAL MARKER; CYTOPLASMIC FMR INTERACTING PROTEIN 2; FRAGILE X MENTAL RETARDATION PROTEIN; RETINOBLASTOMA BINDING PROTEIN; RETINOBLASTOMA BINDING PROTEIN 9; UNCLASSIFIED DRUG;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84859319756     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0885     Document Type: Article

References (30)

1. M. Cozzolino, A. Ferri, M.T. Carri, Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications, Antioxid Redox Signal 10 (2008) 405-443.
2. D.W. Cleveland, J.D. Rothstein, From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS, Nat Rev Neurosci 2 (2001) 806-819. (Pubitemid 33674062)
3. D.R. Rosen, T. Siddique, D. Patterson, D.A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J.P. O'Regan, H.X. Deng et al., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature 362 (1993) 59-62. (Pubitemid 23087289)
4. H.X. Deng, A. Hentati, J.A. Tainer, Z. Iqbal, A. Cayabyab, W.Y. Hung, E.D. Getzoff, P. Hu, B.Herzfeldt, R.P. Roos, et al., Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase, Science 261 (1993) 1047-1051. (Pubitemid 23300865)
5. L.I. Bruijn, T.M. Miller, D.W. Cleveland, Unraveling the mechanisms involved in motor neuron degeneration in ALS, Annu Rev Neurosci 27 (2004) 723-749. (Pubitemid 39050419)
6. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, D.R. Marshak, Multilineage potential of adult human mesenchymal stem cells, Science 284 (1999) 143-147. (Pubitemid 29282067)
7. L.J. Solmesky, M. Abekasis, S. Bulvik, M. Weil, Bone morphogenetic protein signaling is involved in human mesenchymal stem cell survival in serum-free medium, Stem Cells Dev 18 (2009) 1283-1292.
8. Q. Wang, J. Khillan, P. Gadue, K. Nishikura, Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis, Science 290 (2000) 1765-1768. (Pubitemid 32004807)
9. M.J. Palladino, L.P. Keegan, M.A. O'Connell, R.A. Reenan, A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity, Cell 102 (2000) 437-449.
10. M. Higuchi, S. Maas, F.N. Single, J. Hartner, A. Rozov, N. Burnashev, D. Feldmeyer, R. Sprengel, P.H. Seeburg, Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2, Nature 406 (2000) 78-81. (Pubitemid 30460214)
11. S. Maas, S. Patt, M. Schrey, A. Rich, Underediting of glutamate receptor GluR-B mRNA in malignant gliomas, Proc Natl Acad Sci U S A 98 (2001) 14687-14692. (Pubitemid 33121452)
12. S. Maas, Y. Kawahara, K.M. Tamburro, K. Nishikura, A-to-I RNA editing and human disease, RNA Biol 3 (2006) 1-9.
13. R. Brusa, F. Zimmermann, D.S. Koh, D. Feldmeyer, P. Gass, P.H. Seeburg, R. Sprengel, Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice, Science 270 (1995) 1677-1680. (Pubitemid 26002446)
14. Y. Kawahara, K. Ito, H. Sun, H. Aizawa, I. Kanazawa, S. Kwak, Glutamate receptors: RNA editing and death of motor neurons, Nature 427 (2004) 801.
15. Y. Kawahara, S. Kwak, Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons? Amyotroph Lateral Scler Other Motor Neuron Disord 6 (2005) 131-144. (Pubitemid 41419200)
16. Y. Kawahara, S. Kwak, H. Sun, K. Ito, H. Hashida, H. Aizawa, S.Y. Jeong, I. Kanazawa, Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS, J Neurochem 85 (2003) 680-689. (Pubitemid 36531931)
17. S. Kwak, Y. Kawahara, Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis, J Mol Med 83 (2005) 110-120. (Pubitemid 40379299)
18. S. Kwak, Y. Nishimoto, T. Yamashita, Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research, RNA Biol 5 (2008) 193-197.
19. D.C. Colter, R. Class, C.M. Digirolamo, D.J. Prockop, Rapid expation of recycling stem cell in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97 (2000) 3213-3218. (Pubitemid 30183281)
20. M. Dominici, K.L Blanc, I. Mueller, I. Slaper-Cortenbach, F.C Marini, D.S Krause, R.J Deans, A. Keating, D.J Prockop, E.M. Horwitz, Minimal criteria for defining multipotent mesenchymal stromal cells, Cytotherapy 8 (2006) 315-317.
21. R.R. Pochampally, J.R. Smith, J. Ylostalo, D.J. Prockop, Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes, Blood 103 (2004) 1647-1652. (Pubitemid 38268955)
22. E.Y. Levanon, M. Hallegger, Y. Kinar, R. Shemesh, K. Djinovic-Carugo, G. Rechavi, M.F. Jantsch, E. Eisenberg, Evolutionarily conserved human targets of adenosine to inosine RNA editing, Nucleic Acids Res 33 (2005) 1162-1168. (Pubitemid 41439909)
23. E.M. Riedamann, S.Schopoff, J.C. Hartner, M.F. Jantsch, Specificity of ADAR-mediated RNA editing in newly identified targets, Rna 14 (2008) 1110-1118. (Pubitemid 351717491)
24. C.Lagier-Tourenne and D.W. Cleveland, Rethinking ALS: the FUS about TDP-43, Cell. 136 (2009) 1001-1004.
25. J.T. Woitach, M. Zhang, C.H. Niu, S.S. Thorgeirsson, A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability, Nat Genet 19 (1998) 371- 374.
26. S. Cassie, I. Koturbash, D. Hudson, M. Baker, Y. Ilnytskyy, R. Rodriguez-Juarez, E.Weber, O. Kovalchuk, Novel retinoblastoma binding protein RBBP9 modulates sex-specific radiation responses in vivo, Carcinogenesis 27 (2006) 465-474. (Pubitemid 43372875)
27. R.S. Jackson, 2nd, Y.J. Cho, S. Stein, P. Liang, CYFIP2, a direct p53 target, is leptomycin-B sensitive, Cell Cycle 6 (2007) 95-103. (Pubitemid 46178024)
28. A. Schenck, B. Bardoni, A. Moro, C. Bagni, J.L. Mandel, A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P, Proc Natl Acad Sci U S A 98 (2001) 8844-8849. (Pubitemid 32678115)
29. A. Seksenyan, N. Ron-Harel, D. Azoulay, L. Cahalon, M. Cardon, P. Rogeri, M.K. Ko, M. Weil, S. Bulvik, G. Rechavi, N. Amariglio, E. Konen, M. Koronyo-Hamaoui, R. Somech, M. Schwartz, Thymic Involution in Amyotrophic Lateral Sclerosis, J Cell Mol Med 14 (2009) 2470-2482.
30. N. Paz, E.Y. Levanon, N. Amariglio, A.B. Heimberger, Z. Ram, S. Constantini, Z.S. Barbash, K. Adamsky, M. Safran, A. Hirschberg, M. Krupsky, I. Bendov, S. Cazacu, T. Mikkelsen, C. Brodie, E. Eisenber, G. Rechavi Altered adenosine-to-inosine RNA editing in human cancer, Genome Res 17 (2007) 1586-1595. (Pubitemid 350074854)